Effect of vitamin D supplementation on oral glucose tolerance in individuals with low vitamin D status and increased risk for developing type 2 diabetes ( EVIDENCE ): A double‐blind, randomized, placebo‐controlled clinical trial
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: Low serum 25‐hydroxyvitamin‐D (25( OH )D) concentrations are associated with insulin resistance, β‐cell dysfunction and type 2 diabetes. We conducted a 24‐week double‐blind, randomized, placebo‐controlled trial to examine the effect of 28 000 IU of vitamin D 3 once weekly on plasma glucose after a 2 hour‐75 g oral glucose tolerance test ( 2hrPC glucose), insulin sensitivity and β‐cell function. Study Design and Methods: A total of 71 participants with serum 25( OH )D ≤65 nmol/L, impaired fasting glucose and elevated glycated hemoglobin were randomly assigned to receive 28 000 IU of vitamin D 3 ( VitD ; n = 35) or placebo (n = 36) in cheese once weekly for 24 weeks. The primary outcome was the change in 2hPC glucose. Secondary outcomes were fasting glucose, fasting and postprandial insulin, indices of insulin sensitivity and β–cell function, glycated hemoglobin and lipid profile. Participants underwent an oral glucose tolerance test to determine 2hPC glucose. Results: Mean baseline serum 25( OH )D was 48.1 and 47.6 nmol/L in the VitD and placebo groups, respectively. Serum 25( OH )D significantly increased to 98.7 nmol/L (51 nmol/L increase; P < .0001) in the VitD group. No significant differences in fasting ( P = .42) or 2hPC glucose ( P = .55) or other indices of glucose metabolism, including β‐cell function and insulin sensitivity, were observed between groups. A subgroup analysis of individuals with 25( OH )D < 50 nmol/L and prediabetes did not change these results. The VitD group exhibited a significant reduction in LDL cholesterol (−0.27 vs 0.01 mmol/L, P = .03). Conclusion: Weekly doses of vitamin D 3 in individuals with suboptimal vitamin D levels who were at risk for type 2 diabetes did not improve oral glucose tolerance or markers of glycaemic status.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Seltzer, H. S., Allen, E. W., Herron, A. L., & Brennan, M. T. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105534 · Cited by 883 · cited 1×
“The IGI was calculated by dividing the rise in insulin by the rise in glucose from 0 to 30 minutes (ΔI0 − 30/ΔG0 − 30).(19) ISSI-2 is defined as the ratio of the insulin AUC to the glucose AUC multiplied by the Matsuda index.”
MethodCholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Yusuf, S., Bosch, J., Dagenais, G., Zhu, J., Xavier, D., Liu, L., Pais, P., López-Jaramillo, P., Leiter, L. A., Dans, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600176 · Cited by 848 · cited 1×
“These results are important because it is well-known that LDL cholesterol plays a role in arterial plaque formation; hence it increases the risk for cardiovascular disease and stroke (33), the two leading causes of death worldwide (34).”
BackgroundPittas, A. G., Harris, S. S., Stark, P. C., & Dawson-Hughes, B. (2007) · Diabetes Care · doi:10.2337/dc06-1994 · Cited by 643
von Hurst, P. R., Stonehouse, W., & Coad, J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992017 · Cited by 624 · cited 3×
“from a study that included only women and used a fasting measure of insulin sensitivity (HOMA2%S) which is a measure of liver, and not whole body, insulin sensitivity.(6) The main outcome of postchallenge”
BackgroundMethodInfluentialUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
The natural history of impaired glucose tolerance in the Pima Indians
Saad, M. F., Knowler, W. C., Pettitt, D. J., Nelson, R. G., Mott, D. M., & Bennett, P. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812083192302 · Cited by 413 · cited 1×
“1 mmol/L) diabetes risk decreases by 50%.(23) Although we did not expect to see such a large effect, we did expect to see a smaller, albeit clinically meaningful, reduction in risk.”
BackgroundTankova, T., Chakarova, N., Atanassova, I., & Dakovska, L. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.12.020 · Cited by 101 · cited 4×
“Firstly, participants were prescreened via telephone or email using the Finnish Diabetes Risk Score (FINDRISC) (15)”
MethodInfluential
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline
Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae290 · Cited by 639
Lemieux, P., Weisnagel, S. J., Caron, A. Z., Julien, A.-S., Morisset, A.-S., Carreau, A.-M., Poirier, J., Tchernof, A., Robitaille, J., Bergeron, J., et al. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0156 · Cited by 102
The Role of Vitamin D in the Pathogenesis and Treatment of Diabetes Mellitus: A Narrative Review
Grammatiki, M., Karras, S., & Kotsa, K. (2019) · Hormones · doi:10.1007/s42000-018-0063-z · Cited by 54
Metadata
- Authors
- Moreira‐Lucas, T. S., Duncan, A. M., Rabasa‐Lhoret, R., Vieth, R., Gibbs, A. L., Badawi, A., & Wolever, T. M. S.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2016-11-09
- Volume
- 19
- Issue
- 1
- Pages
- 133-141
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2529164329
- Cited by
- 76
- References
- 8
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.